John Herzfeld v. Teva Pharmaceuticals USA, Inc.

District Court, C.D. California·Decided April 14, 2020·No. 2:18-cv-09784·Unknown

Opinion

O

44 55 66 77 88 United States District Court 99 Central District of California

1111 JOHN HERZFELD, Case No. 2:18-cv-09784-ODW (SSx)

1122 Plaintiff, ORDER DENYING PLAINTIFF’S MOTION FOR 1133 v. RECONSIDERATION [65]

INC. OMNIBUS WELFARE PLAN, et al. 1155 Defendants. 1166 1188 Presently before the Court is Plaintiff John Herzfeld’s Motion for 1199 Reconsideration of the Court’s Order granting Defendant MCMC, LLC’s motion to 2200 dismiss (“Motion”). (Mot. for Recons. (“Mot.”), ECF No. 65.) For the reasons that 2211 follow, Plaintiff’s Motion is DENIED.1 2233 The Court addressed the relevant factual allegations and procedural history in 2244 its Order granting Defendant MCMC’s motion to dismiss and incorporates that 2255 discussion here by reference. (See Order Granting MCMC’s Mot. to Dismiss 2266 (“Order”), ECF No. 34.) The following brief summary is provided for context. 2277

2288 1 After considering the papers filed in connection with this Motion, the Court deemed this matter appropriate for decision without oral argument. Fed. R. Civ. P. 78(b); C.D. Cal. L.R. 7-15. John Herzfeld (“Herzfeld”) is a dependent of Jeffrey Herzfeld, who was employed by Teva Pharmaceuticals USA, Inc. (Compl. ¶¶ 2, 8, ECF No. 1.) Teva Pharmaceuticals, Inc. is the Plan Sponsor and Plan Administrator of the Teva Pharmaceuticals USA, Inc. Omnibus Welfare Benefit Plan (the “Plan”), an ERISA- governed welfare benefit plan. (Compl. ¶ 9.) Herzfeld was diagnosed with Duchenne Muscular Dystrophy (“DMD”) at the age of six and was eighteen years old at the commencement of this lawsuit. (Compl. ¶ 14.) DMD has caused Herzfeld “degeneration and weakness in his muscles such that he requires a wheelchair for mobility and effectively has no use of his arms without assistance.” (Compl. ¶ 4.) At his doctors’ recommendation, Herzfeld requested coverage for a myo-electric elbow-wrist orthoses (“EWO”) called the MyoPro. (Compl. ¶¶ 22–27, 57–60.) Herzfeld alleges EWOs have gained widespread acceptance in the medical community, but the claims administrator (“Quantum”) denied Herzfeld’s request for coverage, finding the MyoPro to be “Experimental and/or Investigational.” (Compl. ¶¶ 10, 32, 44, 61.) Quantum also denied Herzfeld’s internal appeals, granted his request for an external review, and assigned independent review organization (“IRO”) MCMC to conduct the de novo external review. (Compl. ¶¶ 67, 72, 74–75.) With some exceptions delineated in the applicable regulations, an external review is final and binding. (See Compl. ¶ 56.) MCMC upheld Quantum’s coverage denial on the ground that the MyoPro was “experimental and investigational.” (Compl. ¶ 76.) Herzfeld initiated this action against MCMC and several other defendants. (See Compl. ¶¶ 9–13.) Herzfeld asserts three causes of action under ERISA against all defendants: (1) denial of benefits under 29 U.S.C. § 1132(a)(1)(B), (2) violation of fiduciary duties under § 1132(a)(3), and (3) denial of full and fair review under § 1133. (Compl. ¶¶ 94–115.) On August 26, 2019, the Court granted MCMC’s motion to dismiss without leave to amend. (Order 11.) The Court found that MCMC was not a proper defendant for any of Herzfeld’s claims because: (1) MCMC had no control over administration of benefits under the Plan; (2) MCMC was not an ERISA fiduciary; and (3) MCMC was not the Plan, the only proper defendant for a claim under § 1133. (Order 6, 10, 11.) At MCMC’s request, the Court entered partial Judgment for MCMC. (J., ECF No. 54.) Herzfeld moves for reconsideration of the Court’s Order dismissing MCMC under Federal Rules of Civil Procedure (“Rule”) 59(e) and 60(b), and Local Rule 7-18. (Mot. 7–8.) “[A] motion for reconsideration [under Rule 59(e)] should not be granted, absent highly unusual circumstances, unless the district court is presented with newly discovered evidence, committed clear error, or if there is an intervening change in the controlling law.” Carroll v. Nakatani, 342 F.3d 934, 945 (9th Cir. 2003). A court may disregard “repeated legal arguments” and “facts that were available earlier in the proceedings.” Zimmerman v. City of Oakland, 255 F.3d 734, 740 (9th Cir. 2001). Rule 60(b) provides for reconsideration of a final judgment, order, or proceeding only upon a showing of (1) mistake, inadvertence, surprise, or excusable neglect; (2) newly discovered evidence; (3) fraud; (4) a void judgment; (5) a satisfied judgment; or (6) another reason that justifies relief. Fed. R. Civ. P. 60(b). Local Rule 7-18 places additional limitations on motions for reconsideration. Similar to the Federal Rules, “[n]o motion for reconsideration shall in any manner repeat any oral or written argument made in support of or in opposition to the original motion.” C.D. Cal. Civ. L.R. 7-18; Rosenfeld v. U.S. Dep’t of Justice, 57 F.3d 803, 811 (9th Cir. 1995). Grounds for a motion for reconsideration are limited to: (a) a material difference in fact or law from that presented to the Court before such decision that in the exercise of reasonable diligence could not have been known to the party moving for reconsideration at the time of such decision, or (b) the emergence of new material facts or a change of law occurring after the time of such decision, or (c) a manifest showing of a failure to consider material facts presented to the Court before such decision. C.D. Cal. L.R. 7-18; see In re Countrywide Fin. Corp. Mortg.-Backed Sec. Litig., 966 F. Supp. 2d 1031, 1036 (C.D. Cal. 2013). Displeasure with the outcome alone is insufficient; unless the moving party shows that one of the factors exists, the Court will not grant reconsideration. See Carroll, 342 F.3d at 945 (“[A] motion for reconsideration should not be granted, absent highly unusual circumstances,” unless one of the factors is present); Arteaga v. Asset Acceptance, LLC, 733 F. Supp. 2d 1218, 1236 (E.D. Cal. 2010) (noting that mere disagreement with court’s conclusions is not sufficient). Reconsideration is an “extraordinary remedy, to be used sparingly in the interests of finality and conservation of judicial resources.” Carroll, 342 F.3d at 945; Collins v. U.S. Citizenship & Naturalization Serv., No. CV 11-9909-JFW (SSx), 2013 WL 776244, at *1 (C.D. Cal. Feb. 6, 2013) (internal quotation marks omitted) (“Motions for reconsideration are disfavored and are rarely granted.”). Whether to grant a motion for reconsideration is within the court’s discretion. McDowell v. Calderon, 197 F.3d 1253, 1255 n.1 (9th Cir. 1999); Arteaga, 733 F. Supp. 2d at 1236. Herzfeld contends that a recent ruling in the Northern District of California requires the Court to reconsider its finding that MCMC is not an ERISA fiduciary. (Mot. 3.) Herzfeld also argues that the Court failed to consider material facts and erred in its application of law. (Mot. 3–4.) The Court finds Herzfeld’s arguments unpersuasive and insufficient to satisfy the taxing burden for reconsideration.2 A. MCMC’s Opposition As a preliminary matter, Herzfeld argues the Court should not consider MCMC’s opposition because it was filed one day late. (Reply 12, ECF No. 68; Opp’n to Mot. (“Opp’n”), ECF No. 66.) MCMC invokes Rule 6(b) to request that the Court consider its

Free access — add to your briefcase to read the full text and ask questions with AI

John Herzfeld v. Teva Pharmaceuticals USA, Inc., (C.D. Cal. 2020).

John Herzfeld v. Teva Pharmaceuticals USA, Inc. (John Herzfeld v. Teva Pharmaceuticals USA, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Ahanchian v. Xenon Pictures, Inc.
624 F.3d 1253 (Ninth Circuit, 2010)
Jesus Briones v. Riviera Hotel & Casino
116 F.3d 379 (Ninth Circuit, 1997)
Charles E. McDowell Jr. v. Arthur Calderon, Warden
197 F.3d 1253 (Ninth Circuit, 1999)
Jacqlyn Smith v. Clark County School District
727 F.3d 950 (Ninth Circuit, 2013)
Pegasus Satellite Television, Inc. v. DirecTV, Inc.
318 F. Supp. 2d 968 (C.D. California, 2004)
Sataki v. Broadcasting Board of Governors
733 F. Supp. 2d 1 (District of Columbia, 2010)
Zimmerman v. City of Oakland
255 F.3d 734 (Ninth Circuit, 2001)
Sprewell v. Golden State Warriors
266 F.3d 979 (Ninth Circuit, 2001)
Del Prete v. Magellan Behavioral Health, Inc.
112 F. Supp. 3d 942 (N.D. California, 2015)
Carroll v. Nakatani
342 F.3d 934 (Ninth Circuit, 2003)